Brief: Bellus Health Reports Qtrly Loss Per Share $0.14

BELLUS Health

13/08/2020 12:25

Aug 13 (Reuters) - BELLUS Health Inc  BLU.TO :
    * BELLUS HEALTH REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS AND
BUSINESS HIGHLIGHTS
    * BELLUS HEALTH INC - PHASE 2B TRIAL DESIGN FOR BLU-5937 IN
REFRACTORY CHRONIC COUGH TO BE ANNOUNCED IN Q3
    * BELLUS HEALTH INC - AS OF JUNE 30, AVAILABLE CASH, CASH
EQUIVALENTS & SHORT-TERM INVESTMENTS TOTALING $74.0 MILLION
    * BELLUS HEALTH - QTRLY LOSS PER SHARE $0.14
    * BELLUS HEALTH - EXPECTS TO INITIATE ADAPTIVE PHASE 2B
TRIAL OF
BLU-5937 ENRICHED FOR HIGHER COUGH COUNT PATIENTS IN Q4

Source text for Eikon:  ID:nBw9hkBKya 
Further company coverage:  BLU.TO 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))